
Mirapex 0.75mg Tablet ER
Marketer
Boehringer Ingelheim
Salt Composition
Pramipexole (0.75mg)
Overview Mirapex 0.75mg Tablet ER
Pramipexole 0.75mg Extended-Release tablets treat Parkinson's disease and restless legs syndrome (characterized by an irresistible urge to move legs, often due to unpleasant sensations). This medication reduces tremors by regulating body movements. Administer Pramipexole 0.75mg ER with food, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and schedule; if a dose is missed, take it immediately upon recall. Complete the entire course of treatment as directed, even if symptoms improve; abruptly ceasing therapy is unsafe without consulting your doctor. Potential side effects include nausea, dry mouth, tiredness, visual disturbances, constipation, and swelling in the extremities. Drowsiness and dizziness are also possible; avoid driving or mentally demanding tasks until the medication's effects are known. Report any unusual mood shifts, heightened libido, compulsive gambling, or excessive spending to your doctor immediately, as these can be serious.
Uses of Mirapex 0.75mg Tablet ER
Parkinson's Disease and restless legs syndrome
Major Benefits of Mirapex 0.75mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Mirapex 0.75mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Mirapex 0.75mg Tablet ER:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Mirapex 0.75mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Mirapex 0.75mg Extended-Release tablet with a meal.
How Mirapex 0.75mg Tablet ER works:
Pramipexole extended-release 0.75mg tablets function by augmenting dopaminergic neurotransmission, thus improving motor control within the central nervous system.
SAFETY ADVICE
AlcoholUNSAFE
Ropinirole 0.75mg extended-release tablets can induce increased sleepiness when combined with alcohol.
PregnancyCONSULT YOUR DOCTOR
The extended-release Mirapex 0.75mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Mirapex 0.75mg Extended-Release tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. This medication's prolactin-suppressing effect could negatively impact lactation.
DrivingUNSAFE
Prolonged-release Mirapex 0.75mg tablets may induce adverse reactions impacting driving capabilities. These tablets can lead to hallucinations—perceiving nonexistent stimuli—potentially impairing driving safety.
KidneyCAUTION
Extended-release Mirapex tablets (0.75mg) require careful administration in individuals with impaired renal function. Dosage modification of Mirapex 0.75mg ER tablets may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Pramipexole extended-release 0.75mg tablets are likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may not be necessary, however, physician consultation is advised.
What if you forget to take Mirapex 0.75mg Tablet ER :
Omit any missed 0.75mg extended-release Mirapex tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mirapex 0.75mg Tablet ER
| Label | Value |
|---|---|
| Type of Compound | Benzothiazole-based compound |
| Potential for Dependence | None. |
| Type of Medication | Nervous system |
| Mechanism of Action | Drugs that stimulate dopamine receptors |
